Utilization practices of low molecular weight heparin in pediatric patients with acquired and congenital heart disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Utilization practices of low molecular weight heparin in pediatric patients with acquired and congenital heart disease

Published:2021-06 Issue: Volume:61 Page:101346
ISSN:1058-9813
Container-title:Progress in Pediatric Cardiology
language:en
Short-container-title:Progress in Pediatric Cardiology

Author:

Ankola Ashish A.,Ghbeis Muhammad B.,Bailey Brianna,Sahakian Lori,Hellinger Amy,Hawkins Beth,Ventresco Courtney,Blume Elizabeth D.,VanderPluym Christina J.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pediatrics, Perinatology, and Child Health

Reference10 articles.

1. Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines;Monagle;Chest,2012

2. Evaluation of enoxaparin dosing requirements in infants and children: better dosing to achieve therapeutic levels;Bauman;Thromb Haemost,2009

3. Enoxaparin for neonatal thrombosis: a call for a higher dose for neonates;Malowany;Thromb Res,2008

4. Dosing and monitoring of enoxaparin (low molecular weight heparin) therapy in children;Ignjatovic;Br J Haematol,2010

5. Retrospective comparison of two enoxaparin dosing and monitoring protocols at a pediatric hospital;Wolsey;Am J Heal Pharm,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP